1. Home
  2. PCT vs KROS Comparison

PCT vs KROS Comparison

Compare PCT & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

HOLD

Current Price

$8.46

Market Cap

1.8B

Sector

Utilities

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$20.29

Market Cap

655.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCT
KROS
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
655.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PCT
KROS
Price
$8.46
$20.29
Analyst Decision
Buy
Buy
Analyst Count
3
12
Target Price
$13.67
$22.20
AVG Volume (30 Days)
3.6M
742.6K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.57
Revenue
$5,660,000.00
$246,718,000.00
Revenue This Year
N/A
$6,924.79
Revenue Next Year
$707.73
N/A
P/E Ratio
N/A
$12.87
Revenue Growth
N/A
37798.31
52 Week Low
$5.40
$9.12
52 Week High
$17.37
$22.55

Technical Indicators

Market Signals
Indicator
PCT
KROS
Relative Strength Index (RSI) 43.41 53.63
Support Level $8.91 $19.76
Resistance Level $9.45 $21.76
Average True Range (ATR) 0.55 0.68
MACD 0.07 -0.25
Stochastic Oscillator 45.61 22.13

Price Performance

Historical Comparison
PCT
KROS

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: